Free Trial

MediPharm Labs (LABS) Competitors

MediPharm Labs logo
C$0.07 0.00 (0.00%)
As of 03:53 PM Eastern

LABS vs. HLS, TGOD, NINE, SUGR, WMD, MDP, HEXO, VIR, ZOM, and WLLW

Should you be buying MediPharm Labs stock or one of its competitors? The main competitors of MediPharm Labs include HLS Therapeutics (HLS), Green Organic Dutchman (TGOD), Delta 9 Cannabis (NINE), SugarBud Craft Growers (SUGR), WeedMD (WMD), Medexus Pharmaceuticals (MDP), HEXO (HEXO), Viridium Pacific Group (VIR), Zomedica Pharmaceuticals Corp. (ZOM.V) (ZOM), and Willow Biosciences (WLLW). These companies are all part of the "drug manufacturers - specialty & generic" industry.

MediPharm Labs vs. Its Competitors

MediPharm Labs (TSE:LABS) and HLS Therapeutics (TSE:HLS) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, risk, media sentiment, earnings, dividends, analyst recommendations, institutional ownership and valuation.

0.7% of MediPharm Labs shares are held by institutional investors. Comparatively, 65.2% of HLS Therapeutics shares are held by institutional investors. 4.5% of MediPharm Labs shares are held by insiders. Comparatively, 0.4% of HLS Therapeutics shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

HLS Therapeutics has a consensus target price of C$4.50, indicating a potential downside of 8.16%. Given HLS Therapeutics' stronger consensus rating and higher probable upside, analysts clearly believe HLS Therapeutics is more favorable than MediPharm Labs.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
MediPharm Labs
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
HLS Therapeutics
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

MediPharm Labs has higher earnings, but lower revenue than HLS Therapeutics. HLS Therapeutics is trading at a lower price-to-earnings ratio than MediPharm Labs, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MediPharm LabsC$39.42M0.74-C$12.05M-C$0.03-2.41
HLS TherapeuticsC$40.13M2.72-C$15.53M-C$1.00-4.91

MediPharm Labs has a net margin of -30.56% compared to HLS Therapeutics' net margin of -38.70%. MediPharm Labs' return on equity of -24.41% beat HLS Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
MediPharm Labs-30.56% -24.41% -7.17%
HLS Therapeutics -38.70%-25.27%-2.89%

MediPharm Labs has a beta of 0.88, meaning that its share price is 12% less volatile than the S&P 500. Comparatively, HLS Therapeutics has a beta of 1.07, meaning that its share price is 7% more volatile than the S&P 500.

In the previous week, MediPharm Labs' average media sentiment score of 0.00 equaled HLS Therapeutics'average media sentiment score.

Company Overall Sentiment
MediPharm Labs Neutral
HLS Therapeutics Neutral

Summary

HLS Therapeutics beats MediPharm Labs on 7 of the 13 factors compared between the two stocks.

Get MediPharm Labs News Delivered to You Automatically

Sign up to receive the latest news and ratings for LABS and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding LABS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LABS vs. The Competition

MetricMediPharm LabsDrug Manufacturers IndustryMedical SectorTSE Exchange
Market CapC$29.05MC$2.17BC$5.52BC$6.26B
Dividend YieldN/A2.92%3.80%6.72%
P/E Ratio-2.414.2428.0454.38
Price / Sales0.74582.79429.531,113.49
Price / Cash1.3010.3535.8483.29
Price / Book0.6411.338.124.96
Net Income-C$12.05MC$21.15BC$3.25BC$301.20M
7 Day PerformanceN/A1.25%0.97%0.51%
1 Month PerformanceN/A6.17%7.36%4.13%
1 Year PerformanceN/A3.88%31.31%25.62%

MediPharm Labs Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LABS
MediPharm Labs
N/AC$0.07
flat
N/A-6.7%C$29.05MC$39.42M-2.41130Gap Down
HLS
HLS Therapeutics
N/AC$4.90
+0.2%
C$4.50
-8.2%
+42.3%C$109.01MC$40.13M-4.9191
TGOD
Green Organic Dutchman
N/AN/AN/AN/AC$89.95MC$31.37M-0.6541Gap Up
High Trading Volume
NINE
Delta 9 Cannabis
N/AC$1.03
+3.0%
N/A+0.0%C$89.36MC$12.87M19.07940News Coverage
Gap Up
SUGR
SugarBud Craft Growers
N/AC$13.00
flat
N/A+57.3%C$88.66MC$575.64M15.6644
WMD
WeedMD
N/AC$0.28
-1.8%
N/A+0.0%C$67.82MC$27.53M-0.66628Gap Up
MDP
Medexus Pharmaceuticals
1.5692 of 5 stars
C$2.80
-4.8%
C$5.49
+96.0%
+26.3%C$62.69MC$100.25M13.3998
HEXO
HEXO
N/AN/AN/AN/AC$38.72MC$124.10M-0.26690
VIR
Viridium Pacific Group
N/AC$0.38
+5.6%
N/A+0.0%C$37.52MC$1.09M-2.97580Gap Up
ZOM
Zomedica Pharmaceuticals Corp. (ZOM.V)
N/AC$0.29
-6.6%
N/A+0.0%C$36.73MN/A-2.6150Gap Down
WLLW
Willow Biosciences
N/AC$0.25
+6.4%
N/A+138.1%C$36.21MC$2.94M-4.5719Gap Up

Related Companies and Tools


This page (TSE:LABS) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners